Single-Cell Genome Sequencing Market

Single-Cell Genome Sequencing Market Size, Share, Growth Analysis, By Product(Instruments, Reagents), By Technology(NGS, PCR), By Workflow(Isolation, Sample preparation), By Disease Area(Cancer, Immunology), By Application(CTCs, Differentiation/ reprogramming), By End-use(Academic & Research Laboratories, Biotechnology & biopharmaceutical companies), By Regional(North America, Asia Pacific) - Industry Forecast 2024-2031


Report ID: UCMIG35H2090 | Region: Global | Published Date: Upcoming |
Pages: 165 | Tables: 55 | Figures: 60

Single-Cell Genome Sequencing Market Insights

Market Overview:

The global market for single-cell genome sequencing (SCGS) was worth USD 730.53 million in 2016, with a projected compound annual growth rate (CAGR) of 14.6% during the forecast period. The market is being driven by increasing research and development (R&D) activities, growing incidences of chronic and severe immune system disorders and cancer, and rising emphasis by companies on product development. Additionally, favorable government policies are expected to contribute to the market's growth over the forecast period.

Single-Cell Genome Sequencing Market, Forecast & Y-O-Y Growth Rate, 2020 - 2028
ForecastGrowthRate
To get more reports on the above market click here to
Get Free Sample

This report is being written to illustrate the market opportunity by region and by segments, indicating opportunity areas for the vendors to tap upon. To estimate the opportunity, it was very important to understand the current market scenario and the way it will grow in future.

Production and consumption patterns are being carefully compared to forecast the market. Other factors considered to forecast the market are the growth of the adjacent market, revenue growth of the key market vendors, scenario-based analysis, and market segment growth.

The market size was determined by estimating the market through a top-down and bottom-up approach, which was further validated with industry interviews. Considering the nature of the market we derived the Biotechnology by segment aggregation, the contribution of the Biotechnology in Pharmaceuticals, Biotechnology & Life Sciences and vendor share.

To determine the growth of the market factors such as drivers, trends, restraints, and opportunities were identified, and the impact of these factors was analyzed to determine the market growth. To understand the market growth in detail, we have analyzed the year-on-year growth of the market. Also, historic growth rates were compared to determine growth patterns.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

The market for Single-Cell Genome Sequencing was estimated to be valued at US$ XX Mn in 2021.

The Single-Cell Genome Sequencing Market is estimated to grow at a CAGR of XX% by 2028.

The Single-Cell Genome Sequencing Market is segmented on the basis of Product, Technology, Workflow, Disease Area, Application, End-use, Regional.

Based on region, the Single-Cell Genome Sequencing Market is segmented into North America, Europe, Asia Pacific, Middle East & Africa and Latin America.

The key players operating in the Single-Cell Genome Sequencing Market are Bio-Rad Laboratories;, 10x Genomics;, Novogene;, Fluidigm;, BGI;, Illumina, Inc.;, Oxford Nanopore Technologies, Pacific Biosciences;, Thermo Fisher Scientific, Inc.; , QIAGEN;, F Hoffmann-La Roche Ltd..

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Single-Cell Genome Sequencing Market

Product ID: UCMIG35H2090

$5,300
BUY NOW GET FREE SAMPLE